29 Jul 2010 15:02
For immediate release | 29 July 2010 |
Alliance Pharma plc
TR-1: Notification of major interests in shares
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii | Alliance Pharma plc | |||
2 Reason for the notification (please tick the appropriate box or boxes): | ||||
An acquisition or disposal of voting rights | Yes | |||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
| |||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
| |||
An event changing the breakdown of voting rights |
| |||
Other (please specify): |
|
| ||
3. Full name of person(s) subject to the notification obligation: iii | Aviva plc & its subsidiaries | |||
4. Full name of shareholder(s) (if different from 3.):iv | Registered Holder:
BNY Norwich Union Nominees Limited 1,138,491*
Chase (GA Group) Nominees Limited 7,360,214*
CUIM Nominee Limited 2,770,404*
*denotes direct interest
BNP Paribas - London 2,237,424
Chase Nominees Limited 7,457,371
State Street Nominees Limited 2,352,851
| |||
5. Date of the transaction and date on which the threshold is crossed or reached: v | 28 July 2010 | |||
6. Date on which issuer notified: | 29 July 2010 | |||
7. Threshold(s) that is/are crossed or reached: vi, vii |
| |||
8. Notified details: | |||||||||||
A: Voting rights attached to shares viii, ix | |||||||||||
Class/type of shares if possible using the ISIN CODE | Situation previous to the triggering transaction | Resulting situation after the triggering transaction | |||||||||
Number of Shares | Number of Voting Rights | Number of shares | Number of voting rights | % of voting rights | |||||||
Direct | Direct xi | Indirect xii | Direct | Indirect | |||||||
Ordinary Shares GB0031030819 | 21,516,755 | 21,516,755 | 23,316,755 | 11,269,109 | 12,047,646 | 4.85% | 5.18% | ||||
| |||||||||||
| |||||||||||
B: Qualifying Financial Instruments | |||||||||||
Resulting situation after the triggering transaction | |||||||||||
Type of financial instrument | Expiration date xiii | Exercise/ Conversion Period xiv | Number of voting rights that may be acquired if the instrument is exercised/ converted. | % of voting rights | |||||||
|
|
|
|
| |||||||
| |||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||
Resulting situation after the triggering transaction | ||||||
Type of financial instrument | Exercise price | Expiration date | Exercise/ Conversion period | Number of voting rights instrument refers to
| % of voting rights
| |
|
|
|
|
| Nominal | Delta |
|
| |||||
Total (A+B+C) | ||||||
Number of voting rights | Percentage of voting rights | |||||
23,316,755 | 10.03% |
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: | ||
The voting rights are managed and controlled by Aviva Investors Global Services Limited, with the following chain of controlled undertakings:-
Aviva Investors Global Services Limited: ·; Aviva plc (Parent Company) ·; Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) ·; Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited) ·; Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited)
| ||
| ||
Proxy Voting: | ||
10. Name of the proxy holder: | See Section 4 | |
11. Number of voting rights proxy holder will cease to hold: |
| |
12. Date on which proxy holder will cease to hold voting rights: |
| |
| ||
13. Additional information: | Figures are based on the total number of voting rights of 232,533,372. | |
14. Contact name: | Diane Thirkettle | |
15. Contact telephone number: | 01603 687803 | |